Insight Molecular Diagnostics Inc. (IMDX) — Capital Reinvestment Ratio

Latest as of September 2014: 1.86x

Insight Molecular Diagnostics Inc. (IMDX) has a Capital Reinvestment Ratio of 1.86x as of September 2014, meaning it reinvests 2% of its operating cash flow ($7.00K) in capital expenditures ($13.00K). See IMDX net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.86x

Capex / Operating Cash Flow

Operating Cash Flow

$7.00K

USD

Capital Expenditures

$13.00K

USD

Data as of

Sep 2014

Most recent filing

Annual Capital Reinvestment Ratio for Insight Molecular Diagnostics Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for Insight Molecular Diagnostics Inc. from None to None. For live market cap and broader valuation context, see IMDX market cap.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow